Demonstration of alterations in the resting and ligand-induced levels, of phosphorylated proteins, including AKT and ribosomal S6, is a powerful tool in the diagnosis of APDS and APDS-L diseases, enabling stratification of patients for treatment, and furthermore monitoring of treatment efficacy. Here, AKT1 is linked to activated PI3K-delta syndrome.